Studies of Cannabinoid-1 Receptor Antagonists for the Treatment of Obesity: Hologram QSAR Model for Biarylpyrazolyl Oxadiazole Ligands

Hologram QSAR studies were conducted on a series of 60 training set of cannabinoid-1 receptor (CB(1)) antagonists. Significant cross-validated correlation coefficients (q2=0.763) and noncross-validated correlation coefficients (r2=0.897) were obtained. The model was then employed to predict the biological activities of 15 test set compounds, and a good agreement between the experimental and predicted values was verified exhibiting a powerful predictable capability of thismodel (qpred2=0.868).



Powered by GlobalLink OneLink Software